CAD and head and neck squamous cell carcinoma: In conclusion, our study indicated that CPS positivity varies according to tumor histology, and the CPS cut‐off value that predicts better clinical outcomes might be higher than in previous reports on R/M‐HNSCC patients treated with APA monotherapy.